baber/WOPTO huggingface dataset:
Patent EP-0711427-B1 (EP)
Inventor: CAILBAULT CHRISTIAN JEAN GERAR
IPC: G06K7/10
Filed: 1994-07-27
Granted: 1997-11-12
Abstract: An apparatus for recognising data on an object such as an envelope containing a photographic film or the like. A first identification sub-assembly (15) such as a bar code data reader is used to operate a second sub-assembly which includes a mobile imaging unit (18).
Patent EP-0722527-B1 (EP)
Inventor: KLOEBER JOHANNES
IPC: E04D1/36
Filed: 1994-08-08
Granted: 2000-03-01
Abstract: A roof ridge sealing strip (1) has a central area (D) that allows the passage of air and two marginal areas (9) corrugated in the longitudinal direction with a stretchable stabilising insert (S) arranged next to their edge and adaptable to the corrugations of the laid roofing plates (6). In order to optimise this strip, both marginal areas (9) are linked to each other by intermediate webs (11) that form a row of perforations (8) in the longitudinal direction.
Patent EP-0673948-B1 (EP)
Inventor: BRUST STEFAN DR
IPC: C07K16/10
Filed: 1995-02-14
Granted: 1998-11-11
Abstract: An immunologically active peptide comprising approximately 15 to 50 (pref. 20-30) consecutive amino acids (AA), selected from the sequence (I) is new:VWGIRQLRAR LQALETLIQN QQRLNLWGX KGKLIXYTSV KWNTSWSGR (I). In (I), X = C or S. Also claimed are: (a) the peptide produced either recombinantly or synthetically; (b) an isolated DNA fragment coding for a peptide as above; and (c) a test kit for the detection of viral antibodies causing immune deficiencies, pref. a Western Blot or an ELISA.
Patent EP-0682024-B1 (EP)
Inventor: HEMMERLE HORST DR
IPC: A61K31/4353
Filed: 1995-05-04
Granted: 1999-12-08
Abstract: Cyclohexane derivs. of formula (I), and their salts, are new. R<2> = O-(3-5C)alkyl-R<11>, in which the alkyl component is straight, branched or cyclic; R<11> = phenyl (opt. 4-substd. by F, Cl or Me); and R<4>, R<5> = H or OH.
Patent EP-0717116-B1 (EP)
Inventor: BELLUS JACQUES
IPC: C21D1/00
Filed: 1995-12-07
Granted: 2001-06-13
Abstract: Micro-alloyed steel consists of (in wt%): 0.05-0.5 C; 1-2 Mn; 0.05-1.55 Si; 0.1-1 Cr; 0-0.5 Mo; 0-0.3 V; 0-0.01 B; 0-0.03 Ti; and 0-0.1Nb. It has a bainitic structure. A blank of the steel is subjected to surface heat treatment by laser beam, induction heating or electron bombardment, followed by quenching. The heat affected zones are heated to 500-900 degrees C and cooled at a rate of above 500 degrees C/hr..
Patent EP-0691047-B1 (EP)
Inventor: CORBACH RAINER
IPC: H01R39/40
Filed: 1995-01-17
Granted: 1999-05-12
Abstract: L'invention a pour objet une machine électrique à commutateur destinée à la commande de groupe générateurs. Elle comprend une plaque-support annulaire (14) entourant l'axe de rotation du commutateur, pour des porte-balais métalliques (20) de forme générale tubulaire, de section carrée, montés rigidement sur celle-ci, dans lesquels sont guidés, le long de l'axe longitudinal des tubes, des balais frotteurs (22) appartenant au dispositif commutateur, s'appliquant, lorsqu'ils sont en place, contre une surface de contact du commutateur. On obtient une construction particulièrement simple et avantageuse de la machine à commutateur, grâce au fait que pour la fixation du porte-balai (20) sur la plaque-support (14), sur l'une des parois (44) du porte-balai, au moins deux languettes (46) sont disposées en saillie par rapport au plan de la paroi, languettes auxquelles sont associées les rainures d'insertion ((52) fixant les languettes (46) et se trouvant dans une extrémité (54, 40) de la plaque-support.
Patent EP-0741792-B1 (EP)
Inventor: DARGAN DERRICK JAMES
IPC: C12N15/86
Filed: 1995-01-25
Granted: 2006-04-05
Abstract: PCT No. PCT/GB95/00156 Sec. 371 Date Jul. 19, 1996 Sec. 102(e) Date Jul. 19, 1996 PCT Filed Jan. 25, 1995 PCT Pub. No. WO95/20049 PCT Pub. Date Jul. 27, 1995This invention is directed toward a new type of herpesvirus particle (e.g., HSV-1), herein designated pre-viral DNA replication enveloped particles (PREPS), and methods of preparing said particles. These particles are non-infectious and can be prepared reliably to a high ratio of HSV-1 PREPS to infectious virus of at least 107:1. PREPS can be produced under conditions wherein viral DNA replication is blocked through the use of suitable drugs (e.g., acyclovir [ACV]; cytosine- beta -D-arabinofuranoside [ara C]) or by using an HSV mutant defective in viral DNA synthesis. Compositions comprising HSV-1 PREPS are disclosed wherein said particles have the following characteristics: a) the PREPS lack a viral capsid; b) the PREPS lack viral DNA; c) the PREPS contain reduced quantities of the proteins 273K (VP1-2), 82/81K (VP13/14), 57K (VP17, gD), and 40K, as compared to HSV-1 L particles; and d) the PREPS contain increased quantities of the proteins 175K (VP4, IE3), 92/91K (VP11/12), and 38K (VP22), as compared to HSV-1 L particles. These particles are useful, inter alia, for the generation of HSV-specific immunological and diagnostic reagents.
Patent EP-0744984-B1 (EP)
Inventor: BATSON RICHARD GUY
IPC: B01D21/00
Filed: 1995-02-15
Granted: 1999-04-07
Abstract: Procédé de séparation de matières particulaires d'un fluide véhicule dans lequel elles se trouvent en suspension. On sépare une première zone d'une masse du fluide véhicule d'une seconde zone de fluide clarifié, et on introduit dans la masse de fluide une suspension de matières particulaires dans un fluide véhicule. On extrait le fluide clarifié de la zone de fluide clarifié, et on permet à la quasi totalité du fluide clarifié pénétrant dans la zone de fluide clarifié de passer de la première zone à la seconde zone par l'intermédiaire d'une zone secondaire dans laquelle s'effectue une séparation au moins partielle des matières particulaires du fluide véhicule, et ce dans un sens contraire au sens de l'écoulement. La section transversale de la zone secondaire est plus petite que celle de la masse de fluide.
Patent EP-0688185-B1 (EP)
Title: Dispositif d'ancrage chirurgicale
Inventor: MARTINS HAROLD M
IPC: F16G11/00
Filed: 1995-01-10
Granted: 2004-03-17
Abstract: Cette invention concerne un dispositif d'ancrage (7a, 7b, 7c) servant à fixer un objet à une structure de type structure osseuse, et à son procédé de déploiement. Le dispositif d'ancrage comprend un corps et une pluralité de barbes ou pointes (44). Les barbes sont placées de façon à être espacées sur la circonférence et alignées dans l'axe, les unes par rapport aux autres autour du corps. Chaque barbe est élastiquement déformable et a une configuration normale qui s'étend vers l'arrière et radialement vers l'extérieur à partir du corps vers une extrémité externe qui est située à l'extérieur d'une partie saillante longitudinale de la plus grande section transversale géométrique du corps, prise transversalement par rapport à son axe longitudinal. Un trou (26) s'étend transversalement dans la partie avant du corps et permet de réceptionner une longueur de matériau du type corde au moyen duquel on peut tirer le dispositif d'ancrage le long d'un canal osseux. Une ouverture (30) s'étend transversalement dans la partie arrière du corps et est conçue pour raccorder l'objet au dispositif d'ancrage. Le procédé consiste à enfiler le matériau de type corde dans le trou; à fixer l'objet à la partie arrière du corps, à enfiler le matériau de type corde dans un canal osseux préformé; à tirer le dispositif d'ancrage dans le canal osseux préformé pour l'amener jusqu'à un endroit se trouvant légèrement au-delà de son point d'ancrage désiré; et à exercer une force de traction vers l'arrière sur l'objet de façon à fixer les extrémités externes des barbes dans la structure osseuse.
Patent EP-0696298-B1 (EP)
Inventor: SUOKAS ESA
IPC: B29L7/00
Filed: 1995-02-28
Granted: 2000-09-06
Abstract: PCT No. PCT/FI95/00115 Sec. 371 Date Oct. 30, 1995 Sec. 102(e) Date Oct. 30, 1995 PCT Filed Feb. 28, 1995 PCT Pub. No. WO95/23180 PCT Pub. Date Aug. 31, 1995The lamellar layer is formed by overlapping plates of the liquid crystalline polymer in the isotropic matrix. The oxygen transmission rate of a 50  mu m thick layer of the monolayer structure is typically less than 150 cm3/(m2xdxbar).
Patent EP-0764210-B1 (EP)
Title: Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
Inventor: KRAMER VANCE CARY
IPC: A01N63/50
Filed: 1995-05-30
Granted: 2006-01-11
Abstract: The present invention is drawn to a novel toxin gene purified and isolated from Bacillus thuringiensis var kurstaki and given the designation CryIE(c). The novel toxin gene encodes a protein of approximately 130 kDa in size and is active against Lepidopteran insects. Also included in the invention are the proteins encoded by CryIE(c). Further disclosed are recombinant genes and proteins derived from CryIE(c). Also provided are biologically pure bacterial strains transformed with the CryIE(c) gene which can be used in entomocidal formulations for the control of Lepidopteran insects. Yet another aspect of the invention are plants transformed with the toxin gene or active fragments thereof, particularly where the transforming sequences have been optimized for expression in maize.
Patent EP-0764073-B1 (EP)
Inventor: FECKER VIKTOR
IPC: B26D1/14
Filed: 1995-05-12
Granted: 1998-08-19
Abstract: The invention concerns a slice-cutting machine (1), in particular a machine for cutting food, with a housing (2) and, mounted in the housing, an electrically driven circular cutter blade (5). In order to improve the ease of servicing of the machine, the invention proposes that the cutter blade (5) is driven directly, i.e. with no reduction gearing, by a motor (11) mounted on the shaft (12) carrying said blade.
Patent EP-0764314-B1 (EP)
Inventor: SCHOONEN ADELBERT JOZEF MARTIN
IPC: G16H20/13
Filed: 1995-06-09
Granted: 1999-09-15
Abstract: A pharmacy system for prescribing and delivering medicaments to a patient includes at least one input unit with which a doctor is capable of entering inter alia a prescription of a medicament for a patient, together with the patient's identity, into the system. The input unit then generates a prescription signal corresponding to the prescription entered. A pharmacy computer coupled to the input unit further processes the prescription signal received from the input unit and generates a control signal corresponding to the prescription. Under the supervision of the control signal generated by the pharmacy computer, an automatic dispenser dispenses the prescribed medicament to the patient.
Patent EP-0763975-B1 (EP)
Inventor: AMMERMANN EBERHARD
IPC: A01N37/50
Filed: 1995-05-27
Granted: 1999-09-08
Abstract: PCT No. PCT/EP95/02025 Sec. 371 Date Dec. 10, 1996 Sec. 102(e) Date Dec. 10, 1996 PCT Filed May 27, 1995 PCT Pub. No. WO95/34203 PCT Pub. Date Dec. 21, 1995A fungicidal mixture containing a) an oxime ether carboxylic acid ester of the formula Ia or Ib    <IMAGE>  Ia   <IMAGE>  Ib  and b) 1-(1,2,4-triazol-1-yl)-2-cyano-2-(4-chlorophenyl)hexane II   <IMAGE>   in a synergistically active amount is described.
Patent EP-0766755-B1 (EP)
Inventor: GANNON JAMES MARTIN
IPC: D04H1/4266
Filed: 1995-06-19
Granted: 1999-12-15
Abstract: PCT No. PCT/GB95/01439 Sec. 371 Date Dec. 4, 1996 Sec. 102(e) Date Dec. 4, 1996 PCT Filed Jun. 19, 1995 PCT Pub. No. WO95/35399 PCT Pub. Date Dec. 28, 1995The fibrillation tendency of solvent-spun fiber can be increased by subjecting the fiber to a treatment which reduces its degree of polymerisation by about 200 units or more. Suitable methods of treatment include severe bleaching, for example application of an aqueous liquor containing 0.1 to 10 percent by weight sodium hypochlorite (as available chlorine) to the fiber followed by steaming. Fiber may be treated in never-dried or previously-dried form. Fiber treated by the process of the invention is useful for example in the manufacture of paper and hydroentangled fabrics. Fiber of increased tendency to fibrillation can be beaten to a Canadian Standard Freeness 400 in the Disintegration Test by 30,000-150,000 disintegrator revolutions and to a Canadian Standard Freeness 200 in the same Test by 50,000-200,000 disintegrator revolutions.
Patent EP-0716689-B1 (EP)
Inventor: BEUG HARTMUT
IPC: C12N5/08
Filed: 1995-06-28
Granted: 2002-10-02
Abstract: PCT No. PCT/EP95/02516 Sec. 371 Date Apr. 29, 1996 Sec. 102(e) Date Apr. 29, 1996 PCT Filed Jun. 28, 1995 PCT Pub. No. WO96/00777 PCT Pub. Date Jan. 11, 1996Process for the in vitro production of non-immortalised haematopoietic progenitor cells of the erythroid lineage, in which a population of erythroid progenitor cells is exposed to a combination of growth factors containing a glucocorticoid and an oestrogen and at least one ligand of a tyrosine kinase receptor at least until the cells begin to renew themselves.
Patent EP-0773713-B1 (EP)
Inventor: LANTING FEICO
IPC: A23C19/076
Filed: 1995-07-13
Granted: 1999-06-16
Abstract: Process for preparing fresh cheese having a fancy shape wherein fresh cheese is extruded through a nozzle in such condition that the shape of the product as extruded does not collapse and fancy shaped portion of fresh cheese is obtained.
Patent EP-0781271-B1 (EP)
Inventor: OHKAWA SHIGENORI
IPC: C07C275/34
Filed: 1995-09-11
Granted: 2000-06-07
Abstract: A compound of the formulawherein R1 and R2 are H, a hydrocarbon group or a heterocyclic group, or R1 and R2 are combinedly a spiro ring; R3 is a hydrocarbon group, a substituted amino group, a substituted hydroxyl group or a heterocyclic group; R4 is H or alkyl; ring A is a substituted benzene ring; m and n denote 1 to 4; {overscore (.........)} means a single or double bond or a salt, a process of producing thereof and a composition having a binding affinity for melatonin receptor.
Patent EP-0732862-B1 (EP)
Inventor: SAITO YUKICHI
IPC: H04W36/32
Filed: 1995-10-03
Granted: 2006-07-05
Abstract: Au moment de la commande de commutation de la zone de desserte d'un appareil téléphonique mobile, lorsque le téléphone se déplace d'une première zone de desserte vers une seconde zone de desserte, le chemin optimal coïncidant à la deuxième zone de desserte est retenu comme voie de communication. Un contrôleur de desserte (6) est prévu sur le réseau de communication mobile. Des dispositifs (7) d'information sur les n÷uds de desserte des centraux communiquent chacun au contrôleur (6) des informations sur les n÷uds de desserte des centraux correspondant à leur propre n÷ud au niveau des n÷uds de desserte des centraux (151, 131 et 132). Le contrôleur de desserte (6) comporte un dispositif de mémorisation (8) qui mémorise les données sur les n÷uds de desserte des centraux et un contrôleur (9) d'exécution de commutation prenant en charge la commutation. Lorsque la zone de desserte change, tandis que l'appareil téléphonique mobile (1) se déplace tout en communiquant avec un terminal fixe (5) d'un autre réseau, le contrôleur (9) détermine lequel est le n÷ud passerelle (151) du central répéteur de la voie utilisée pour la communication en cours sur la base des informations mémorisées dans le dispositif de mémorisation (8), puis il ordonne l'établissement d'une voie à partir du n÷ud (151) en direction du n÷ud (132) de desserte du central de l'abonné de la zone de desserte dans laquelle l'appareil téléphonique mobile se trouve.
Patent EP-0800411-B1 (EP)
Inventor: ANJUR SRIRAM PADMANABHAN
IPC: D04H1/42
Filed: 1995-12-21
Granted: 2002-03-27
Abstract: L'invention porte sur une structure absorbante élastomère contenant des fibres discontinues mouillables et des fibres élastomères thermoplastiques. La structure absorbante élastomère présente des propriétés élastiques améliorées par rapport à une structure absorbante par ailleurs sensiblement identique, mais dépourvue de fibres élastomères thermoplastiques. L'invention porte également sur article absorbant jetable (11) contenant cette structure absorbante élastomère.
Patent EP-0763554-B1 (EP)
Inventor: SHAFFER MYRON W
IPC: C08G18/79
Filed: 1996-09-02
Granted: 2003-03-19
Abstract: The present invention relates to a polyisocyanates containing allophanate groups and optionally isocyanurate groups that are prepared by reacting compounds which   i) are substantially free of hydroxyl groups and isocyanate groups,   ii) have an average of at least two urethane groups per molecule and   iii) are the reaction products of linear or branched, aliphatic isocyanates with organic hydroxyl compounds, with an excess quantity, based on the urethane groups, of 4,4'-bis-(isocyanatocyclohexyl)-methane to form polyisocyanates containing allophanate groups and optionally isocyanurate groups and optionally removing at least a portion of the unreacted excess 4,4'-bis-(isocyanatocyclohexyl)-methane. The present invention also relates to a process for the production of these polyisocyanates and to their use as binders or binder components in coating compositions.
Patent EP-0840264-B1 (EP)
Inventor: ORNSTEIN MARVIN A
IPC: G07F17/32
Filed: 1996-11-04
Granted: 2003-01-29
Abstract: An electronic gaming system includes a processor (90) and game progress monitor (92) to allow a player to wager varying amounts on whether that player will have multiple consecutive wins of the game of chance. The system can be incorporated in a gaming table with multiple player video screens (16) and bet selectors (18, 19) or in a single play slot machine type device (25). <IMAGE>
Patent EP-0778591-B1 (EP)
Inventor: GALERNE FRANCOIS
IPC: H01B13/02
Filed: 1996-11-28
Granted: 1999-08-11
Abstract: The cable manufacturing machine produces twisted pair cables with two or more pairs (11) of insulated wires (12), . The individual wires are twisted (15) into pairs, then pairs are twisted together (18). Before the pairs are twisted together to form the cable they are wrapped in a screening tape. The tape is delivered from stock reels (38), feeding the tape into a winder plate (24) along with the pairs to that each pair is wrapped in the screening tape before the pairs are twisted together (18).
Patent EP-0804674-B1 (EP)
Inventor: LASSEN GERT GODVIG
IPC: E06B9/32
Filed: 1996-01-17
Granted: 1998-09-30
Abstract: PCT No. PCT/DK96/00027 Sec. 371 Date Jun. 24, 1997 Sec. 102(e) Date Jun. 24, 1997 PCT Filed Jan. 17, 1996 PCT Pub. No. WO96/22447 PCT Pub. Date Jul. 25, 1996An operating arrangement for an electrically operated window screening device of the type comprising a flexible screening body (1) which is rolled up on a roller (2) positioned in or at an upper horizontal main frame or sash member of the window and in a free end is connected with a bottom rail (4) extending the width of the window. The operating arrangement comprises a cord or string-formed pull-element (12, 13; 24) acting on the screening body and being wound on a winding device (11; 22, 23) positioned at a lower main frame or sash member, with an accompanying electrical drive motor (9). For moving the screening body (1) in an unrolling direction, the pull-element (12, 13; 24) is guided from the winding device along both opposite main frame or sash side sections of the window for connection with the bottom rail (4), whereas the movement of the screening body in the opposite rolling up direction is effected by a spring force acting on said roller (2) during simultaneous unwinding of the pull-element from the winding device. The pull-element (12, 13; 24) may be connected with a separate bar profile (5) designed for after-mounting on a bottom rail (4) for a screening device already installed.
Patent EP-0815625-B1 (EP)
Inventor: BROOKS KEVIN
IPC: H02G5/00
Filed: 1996-03-15
Granted: 2002-07-03
Abstract: A length of busbar 1 carries elongate conductors 2,3,4,5 extending beyond the end of said length and straddled by two side plates 6 and 7 which provide means on which a cover may be mounted. The side plates 6,7 are fastened to a known joint pack 2 for joining conductor lengths, with said plates extending into slots 9,10 of the pack and with plate flanges 6f, 7f attached to the bus bar. Two further side plates 6a, 7a straddle adjoining conductor lengths. The joint area is protected by the cover which is mounted to the side plates on angle brackets or by cover flanges engaging plate regions 12, 12b. Lengths of busbar are interconnected by self-piercing rivets.
Patent EP-0862916-B1 (EP)
Title: utilisation topique de la vitamine D pour le traitement de maladies ophtalmiques
Inventor: KITA KIYOSHI
IPC: A61K31/59
Filed: 1996-04-22
Granted: 2003-03-05
Abstract: Cette invention concerne une composition ophtalmique destinée au traitement et au conditionnement de tissus endommagés dans la région de l'oeil, laquelle composition contient de l'ergocalciférol ou du cholécalciférol, plus précisément une vitamine D, en qualité d'ingrédient actif. Cette invention concerne également une composition ophtalmique utilisée dans le traitement et la prévention de perturbations du métabolisme des tissus de l'oeil, et comprenant une vitamine D ou une vitamine D active en qualité d'ingrédient actif. Cette invention concerne enfin une composition ophtalmique ou dermatologique permettant de protéger la peau ou les yeux contre les rayonnements UV nocifs, et comprenant une vitamine D ou une vitamine K en qualité d'ingrédient actif. La composition ophtalmique permet de normaliser la transparence ou la réfraction des globes oculaires lorsqu'elle est administrée dans la région de l'oeil. Administrée de manière similaire, cette composition ophtalmique contribue également à la modification, à la cicatrisation ou à la prévention de symptômes dus à une perturbation du métabolisme dans les tissus des yeux. La composition dermatologique assure la protection de la peau contre les rayonnements UV nocifs ainsi que celle du cuir chevelu contre ces mêmes rayonnements, et permet ainsi d'enrayer la dépilation. L'application d'un agent cosmétique pouvant inhiber la synthèse de vitamine D dans la peau, il est possible d'administrer de la vitamine D à la peau en incorporant une composition dermatologique contenant de la vitamine D audit agent cosmétique.
Patent EP-0832222-B1 (EP)
Inventor: BOGAERT THIERRY
IPC: C07K16/18
Filed: 1996-05-31
Granted: 2006-07-26
Abstract: UNC-53 protein of <u>C. elegans</u> or its functional equivalent is identified as a signal transducer/integrator involved in controlling the rate and directionality of cell migration and/or cell shape. Nucleic acid sequences encoding UNC-53 protein or its functional equivalent, such as genomic or cDNA are used to transfect <u>C. elegans</u> or mammalian cell lines useful for identifying inhibitors or enhancers of the UNC-53 protein. Any of the inhibitors or enhancers identified or the UNC-53 protein itself or sequences encoding UNC-53 protein can be used in the preparation of medicament for treatment of neurological conditions such as Alzheimer's or Huntingdon's disease, peripheral neuropathies for inhibition of metastasis.
Patent EP-0837892-B1 (EP)
Inventor: HUTCHINGS DAVID A
IPC: C08G61/02
Filed: 1996-07-09
Granted: 2001-11-14
Abstract: The present invention is directed to the formation of phenol alkylation polymers which release negligible phenol and formaldehyde emissions. The phenol aralkylation polymers of the present invention are derived from a phenolic monomer, at least one styrene derivative and an aryl diolefin. In addition to the phenolic monomer, styrene derivative and aryl diolefin, other reactants may be introduced to produce a product with particular properties.
Patent EP-0961831-B1 (EP)
Inventor: YU GUO-LIANG
IPC: C12Q1/68
Filed: 1996-08-16
Granted: 2008-10-29
Abstract: The present invention concerns a novel member of the tumor necrosis factor (TNF) family of cytokines. In particular, isolated nucleic acid molecules are provided encoding the endokine alpha protein. Endokine alpha polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. Also provided are diagnostic and therapeutic methods concerning TNF family-related disorders.